ID: ALA201079

Max Phase: Preclinical

Molecular Formula: C23H28O5

Molecular Weight: 384.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCOc1ccc(C(=O)c2ccc(OCC(C)C)c(CCC(=O)O)c2)cc1

Standard InChI:  InChI=1S/C23H28O5/c1-4-13-27-20-9-5-17(6-10-20)23(26)19-7-11-21(28-15-16(2)3)18(14-19)8-12-22(24)25/h5-7,9-11,14,16H,4,8,12-13,15H2,1-3H3,(H,24,25)

Standard InChI Key:  JRVGSKYRNMMJGV-UHFFFAOYSA-N

Associated Targets(Human)

Transcription factor AP1 124 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 384.47Molecular Weight (Monoisotopic): 384.1937AlogP: 4.76#Rotatable Bonds: 11
Polar Surface Area: 72.83Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.90CX Basic pKa: CX LogP: 5.32CX LogD: 2.11
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.57Np Likeness Score: -0.33

References

1. Tsuchida K, Chaki H, Takakura T, Kotsubo H, Tanaka T, Aikawa Y, Shiozawa S, Hirono S..  (2006)  Discovery of nonpeptidic small-molecule AP-1 inhibitors: lead hopping based on a three-dimensional pharmacophore model.,  49  (1): [PMID:16392794] [10.1021/jm050550d]

Source